Literature DB >> 22203093

Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy.

Huimin Wang1, Ziru Yan, Minyue Dong, Xiaojun Zhu, Hanzhi Wang, Zhengping Wang.   

Abstract

PURPOSE: To investigate whether bile acids transporters organic anion transporting polypeptides 1A2 (OATP1A2), organic anion transporting polypeptides 1B1 (OATP1B1), organic anion transporting polypeptides 1B3 (OATP1B3) were differently expressed in placenta of intrahepatic cholestasis of pregnancy (ICP).
METHODS: Thirty pregnant women with ICP were recruited and 30 normal pregnant women served as control. The expression of mRNA and protein were analyzed by real-time PCR and Western blotting. The localization of OATP1A2, OATP1B1, OATP1B3 were investigated by immunohistochemistry.
RESULTS: The expression of mRNA and protein of both OATP1A2 and OATP1B3 were significantly lower in ICP placenta than normal placenta (P < 0.05). OATP1B1 mRNA was detected by RT-PCR in 8 ICP placentas and 7 control placentas, but protein expression of OATP1B1 was not found in any of the 60 placentas. By immunohistochemistry we found that OATP1A2 was obviously localized to vasculo-syncytial membrane (VSM) and apical surface of syncytiotrophoblasts, while OATP1B3 was localized to VSM of the syncytiotrophoblasts.
CONCLUSIONS: The expression of OATP1A2 and OATP1B3 in placenta decreased in ICP. The down-regulation of these transporters may be involved in the pathophysiology of ICP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22203093     DOI: 10.1007/s00404-011-2183-4

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  9 in total

Review 1.  Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy.

Authors:  Sebiha Ozkan; Yasin Ceylan; Orhan Veli Ozkan; Sule Yildirim
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

2.  Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine.

Authors:  Qingquan Zeng; Mengru Bai; Cui Li; Shuanghui Lu; Zhiyuan Ma; Yunchun Zhao; Hui Zhou; Huidi Jiang; Dongli Sun; Caihong Zheng
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 3.  Effect of Liver Disease on Hepatic Transporter Expression and Function.

Authors:  Nilay Thakkar; Jason R Slizgi; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2017-04-30       Impact factor: 3.534

Review 4.  Unfolding newer concepts in placental pathology of obstetric cholestasis-a cause for prematurity.

Authors:  Anusha Devalla; Kriti Srivastava
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-02-15

5.  Role of Uptake Transporters OAT4, OATP2A1, and OATP1A2 in Human Placental Bio-disposition of Pravastatin.

Authors:  Valentina M Fokina; Svetlana Patrikeeva; Xiao-Ming Wang; Saki Noguchi; Masatoshi Tomi; Jörg König; Mahmoud S Ahmed; Tatiana Nanovskaya
Journal:  J Pharm Sci       Date:  2021-09-28       Impact factor: 3.534

Review 6.  An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics.

Authors:  Ahizechukwu C Eke
Journal:  J Basic Clin Physiol Pharmacol       Date:  2021-12-08

Review 7.  Tenofovir alafenamide use in pregnant and lactating women living with HIV.

Authors:  Ahizechukwu C Eke; Kristina M Brooks; Rahel D Gebreyohannes; Jeanne S Sheffield; Kelly E Dooley; Mark Mirochnick
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-03-17       Impact factor: 4.936

Review 8.  Placental transporter localization and expression in the Human: the importance of species, sex, and gestational age differences†.

Authors:  Natasha Walker; Panagiotis Filis; Ugo Soffientini; Michelle Bellingham; Peter J O'Shaughnessy; Paul A Fowler
Journal:  Biol Reprod       Date:  2017-04-01       Impact factor: 4.285

Review 9.  The Regulation of Steroid Action by Sulfation and Desulfation.

Authors:  Jonathan W Mueller; Lorna C Gilligan; Jan Idkowiak; Wiebke Arlt; Paul A Foster
Journal:  Endocr Rev       Date:  2015-07-27       Impact factor: 19.871

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.